Dr. Pawel T. Pomianowski, MD

Dr. Pomianowski practices at ChristianaCare Adult Outpatient Psychiatry & Therapy in Newark, Delaware.

Dr. Pomianowski's NPI, 1659586352, was assigned on May 14, 2007. Dr. Pomianowski graduated from University of Medical Science Poznan in 1998. Dr. Pomianowski holds Mississippi license 31957.

Dr. Pomianowski's primary practice is ChristianaCare Adult Outpatient Psychiatry & Therapy, at 4755 Ogletown Stanton Road, Newark, DE 19713. The practice phone is (302) 320-2926.

Dr. Pomianowski's primary practice is ChristianaCare Adult Outpatient Psychiatry & Therapy in Newark, Delaware. Dr. Pomianowski is also affiliated with University of Mississippi Medical Center. The medical group on file is University of Mississippi Medical Center. Dmand AI also links Dr. Pomianowski to 2 more medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pomianowski practices, 3 sites in all. Vendor and product names are available with a free account.

Clinical genetics (m.d.) is Dr. Pomianowski's primary specialty in the NPI Registry, under taxonomy code 207SG0201X. Dr. Pomianowski is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Pomianowski's licenses on file in 5 states: Mississippi, Connecticut, Delaware, Montana and Pennsylvania.

Dmand AI lists aneurysm, cardiomyopathy, epilepsy, high cholesterol, muscle disease, muscle weakness, neuropathy and non-alzheimer's dementia (chronic) among the conditions Dr. Pomianowski treats.

CMS data shows 47 Medicare services from Dr. Pomianowski across 2 procedure codes in 2024, all of them office visits, for 26 Medicare patients. Medicare paid $5,819 for them. Every service was in an office.

CMS counts 26 Medicare patients who saw Dr. Pomianowski in 2024. The largest group is 65 to 74, with 12 patients. 73% of them have high blood pressure, and 58% have high cholesterol. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pomianowski's median patient age at 40, with 69% women.

In 2019, Dr. Pomianowski wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $7 in total drug cost.

Dr. Pomianowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pomianowski as offering telehealth.

Dmand AI links 5 papers to Dr. Pomianowski, published from 2022 to 2024. The most frequent topics are Genetic Predisposition to Disease and Phenotype. Dr. Pomianowski's most frequent co-authors are John A. Elefteriades, MD, Daniel Jacoby and John Robert Pollard, MD.

CMS Open Payments shows 34 general payments to Dr. Pomianowski from 11 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $447.

Dr. Pomianowski graduated from University of Medical Science Poznan in 1998.

Dr. Pomianowski is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.